Spanish drugmaker Grifols says Brookfield’s potential €6.45-billion offer undervalues the company

  • Posted on November 19, 2024
  • By The Globe and Mail
  • 3 Views
Spanish drugmaker Grifols says Brookfield’s potential €6.45-billion offer undervalues the company

Earlier on Tuesday, Brookfield said it was considering a public offer for Grifols at €10.50 per A share and €7.62 per B share, implying a company valuation of €6.45-billion
continue reading...

Author
The Globe and Mail

You May Also Like